Anti-EGFR Top1i ADC
搜索文档
ALX Oncology(ALXO) - 2025 Q3 - Earnings Call Presentation
2025-11-07 21:30
Q3 2025 Results November 7, 2025 NASDAQ GS ALXO Certain information set forth in this presentation contains "forward-looking information", under applicable laws collectively referred to herein as forward-looking statements. Except for statements of historical fact, information contained herein constitutes forward-looking statements and includes, but is not limited to the (i) results and cost and timing of our product development activities and clinical trials; (ii) completion of the Company's clinical trial ...